Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02551770 · ClinicalTrials.gov registry record · NA

Emdogain Minimally Invasive Surgical Technique

A NA study, sponsored by Institut Straumann.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT02551770 is a NA study that has completed, run by Institut Straumann. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02551770, a NA study, has completed, sponsored by Institut Straumann.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

The aim of this controlled study is to assess the clinical outcomes and patient reported outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct (test treatment) or without Straumann Emdogain (control treatment).

Interventions

  • PROCEDURE Scaling and root planing
  • PROCEDURE Scaling and root planing without Emdogain
  • DEVICE Emdogain application

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2015-10
Est. Completion 2019-08-30
Phase NA

Sponsor

Institut Straumann

7 total trials

What the Registry Record Tells You About NCT02551770

The ClinicalTrials.gov registry entry for NCT02551770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institut Straumann, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Scaling and root planing is the first listed.

NCT02551770 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02551770 about?

NCT02551770 is a clinical study titled "Emdogain Minimally Invasive Surgical Technique". The aim of this controlled study is to assess the clinical outcomes and patient reported outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct (test treatment) or without Straumann Emdogain (control treatment).

What is the current status of trial NCT02551770?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2015-10. Estimated completion is 2019-08-30.

What interventions are being tested in trial NCT02551770?

The interventions under investigation include: Scaling and root planing (PROCEDURE), Scaling and root planing without Emdogain (PROCEDURE), Emdogain application (DEVICE).

Who is sponsoring clinical trial NCT02551770?

This trial is sponsored by Institut Straumann, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.